TrxR/EGFR-IN-1

TrxR/EGFR-IN-1 (Compound L1Au2) is a dual inhibitor effective against gefitinib-sensitive and -resistant lung cancer models. It induces ferroptosis via GPX4 degradation and triggers immunogenic cell death through endoplasmic reticulum stress, applicable for studying drug resistance mechanisms in both cellular and animal studies.